In the News..

At Defense Diagnostics Inc. (DDI), we are proud to be at the forefront of innovation in harm reduction and diagnostic technology. Our work continues to gain national attention as we develop science-driven tools to combat the fentanyl epidemic and improve public safety.

Our flagship consumer brand, DEFENT, is helping shift the conversation around drug safety by making substance testing accessible, discreet, and stigma-free. From coverage in major news outlets to features in public health forums, DEFENT is elevating awareness and driving meaningful impact across communities.

As a leader in rapid diagnostic development, Defense Diagnostics Inc. remains committed to advancing solutions that save lives and empower individuals to make informed decisions.

Stay tuned here for the latest media features, articles, and industry recognition.